Definition

A drug used to treat adults with folate receptor alpha–positive ovarian epithelial, fallopian tube, or primary peritoneal cancer that has not gotten better after treatment with platinum chemotherapy. It is used in patients whose cancer was treated with one to three other systemic therapies. It is also being studied in the treatment of other types of cancer. Mirvetuximab soravtansine contains a monoclonal antibody that binds to a protein called folate receptor alpha, which is found on some cancer cells. It also contains an anticancer drug, which may help kill cancer cells. Mirvetuximab soravtansine is a type of antibody-drug conjugate. Also called Elahere.